Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice consensus recommendations.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Locally advanced cervical cancer and para-aortic lymphadenectomy: impact of the number of removed lymph nodes, a FRANCOGYN group study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Long-term Results of Hypofractionated Radiotherapy With Intra-prostatic Boosts in Men With Intermediate- and High-risk Prostate Cancer: A Phase II Trial.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Stereotactic Body Radiotherapy for Oligoprogression in Castration-Resistant Prostate Cancer: Early Toxicity Analysis of the TRAP Trial.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Fragmentation of Single-Particle Strength around the Doubly Magic Nucleus  ^{132}Sn and the Position of the 0f_{5/2} Proton-Hole State in ^{131}In.

Physical review letters·2020

Related Experiment Video

Updated: Mar 31, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio.

J Uzan1, A E Nahum1, I Syndikus2

  • 1Physics Department, Clatterbridge Cancer Centre, Bebington, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|October 21, 2015
PubMed
Summary
This summary is machine-generated.

This study on radiobiologically guided dose-painting radiotherapy for high-risk prostate cancer showed promising tumor control probability. The treatment demonstrated low toxicity, with minimal late side effects observed in a small patient group.

Keywords:
Dose-paintingprostate cancerradiobiological modellingtoxicity

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Related Experiment Videos

Last Updated: Mar 31, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • High-risk prostate cancer requires advanced radiotherapy techniques for optimal outcomes.
  • Dose-painting radiotherapy allows for escalated doses to tumor subvolumes.
  • Radiobiological modeling aids in optimizing radiation dose prescription.

Purpose of the Study:

  • To evaluate the efficacy and toxicity of radiobiologically guided dose-painting radiotherapy.
  • To assess treatment outcomes in 11 patients with high-risk prostate cancer.

Main Methods:

  • Functional magnetic resonance imaging (fMRI) identified boost volumes in 11 high-risk prostate cancer patients.
  • A dose-painting approach delivered a boost dose up to 86 Gy in 37 fractions.
  • Rotational intensity-modulated radiotherapy with daily image guidance and fiducial markers was employed, maintaining rectal normal tissue complication probability (NTCP) at 5-6%.

Main Results:

  • Tumor control probability (TCP) increased from 71% to 83.6% with dose-painting.
  • Mean rectal bleeding NTCP was 5.2%, and fecal incontinence NTCP was 5.2%.
  • Low acute toxicity was observed; no grade 3 late toxicity occurred. Two patients experienced grade 2 late urinary toxicity, and two had late rectal toxicity (grade 1-2).

Conclusions:

  • Radiobiologically guided dose-painting radiotherapy shows low toxicity in a small cohort of high-risk prostate cancer patients.
  • Further clinical trials are necessary to establish the benefits of this advanced radiotherapy approach.